Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment

Squamous cell carcinoma of the prostate is rare and represents 0.5% to 1% of prostatic carcinomas. Transformation of prostatic adenocarcinoma into squamous cell carcinoma after LH-RH agonist intake has been reported in only 8 cases in the literature. To our knowledge, our case is the second pure squ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichaoui, Hamza, Nasr, Sonia Ben, Gargouri, Faten, Zribi, Aref, Hermi, Amine, Fendri, Sana, Balti, Mehdi, Ayari, Jihen, Khiari, Ramzi, Msakni, Issam, Mansouri, Nada, Ghozzi, Samir, Haddaoui, Abderrazek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906544/
https://www.ncbi.nlm.nih.gov/pubmed/33708294
http://dx.doi.org/10.11604/pamj.2019.34.125.19421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906544/
https://www.ncbi.nlm.nih.gov/pubmed/33708294
http://dx.doi.org/10.11604/pamj.2019.34.125.19421

Ejemplares similares